KC’s Selected Representative Invited/Keynote/Plenary Lectures

  • Acetolactate Synthase Inhibitors as Novel Anti-tuberculosis Agents. Plenary lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 31 Aug -5 Sept 2003, Queens’ College, University of Oxford, UK.
  • Synthetic Studies Towards Chemical Libraries of New Antimalarial Natural Product Derivatives. Invited lecture at the International Union of Pure and Applied Chemistry International Conference on Biodiversity and Natural Products: Chemistry and Medical Applications, 26-31 Jan 2004, New Delhi (India).
  • Antiparasitic Drug Discovery Using Natural Product-Derived Scaffolds and Multi-Component Reactions. Plenary lecture at the 11th Natural Products Research for East & Central Africa (NAPRECA) Symposium on Natural Products and Drug Discovery, 9-12 August 2005, Antananarivo, Madagascar.
  • A Pharmacophore for the Rational Design of Chemosensitizers Against Drug Resistant Malaria Parasites. Invited lecture at the American Chemical Society(ACS)-Council for Scientific and Industrial Research, CSIR, (India) conference on Advances in Organic Chemistry and Chemical Biology (AOCCB), 11-12 Jan 2006, Indian Institute of Chemical Technology (IICT), Hyderabad, India.
  • Privileged Structures and Multi-Component Reaction Strategies in Antiprotozoal Drug Discovery. Invited lecture at the Keystone Symposia, Drugs Against Protozoan Parasites, 28 Jan-1 February 2007, Lake Tahoe, Tahoe City, California, USA.
  • Medicinal Chemistry in Parasitology Using Promiscuos Chemical Scaffolds. Invited lecture at the European Union COST B22 (Drug Development for Parasitic Diseases) “Medicinal Chemistry in Parasitology: new avenues in drug discovery” meeting, 19-20th February 2007, Modena, Italy.
  • Economic Drug Discovery and Rational Medicinal Chemistry for Tropical Diseases. Invited lecture at the European Union COST B22 Action meeting on Chemotherapy of Tropical Diseases, 10-13th June 2007, Dundee, Scotland, UK.
  • Experiences in Establishing an African Natural Products Network. Invited lecture at the Drugs for Neglected Diseases Initiative (DNDi) and the Malaysian Ministry of Science, Technology and Innovation, Natural Substances Drug Discovery and Development meeting, 29 November-01 December 2007, Petaling Jaya, Malaysia.
  • Unique Models for Collaborative Drug Discovery Networks and Partnerships in Africa. Invited lecture at the Keystone Symposia, Translating New Technologies to Improve Public Health in Africa, 15-20 May 2008, Speke Resort & Conference Centre, Kampala, Uganda.
  • Challenges in Discovering and Developing Drugs Against Malaria. Invited Lecture at the International Centre for Science-United Nations Industrial Development Organization (ICS-UNIDO) Seminar Series, Trieste, Italy, 12 March 2009.
  • Chemical Approaches to the Reversal of Chloroquine Resistance in the Malaria Parasite Plasmodium falciparum. Invited Keynote Lecture at the 7th Asian International Medicinal Chemistry (AIMECS09) Congress, Cairns, Australia, 23-27 August 2009.
  • Challenges in Discovering and Developing Drugs Against Malaria in Africa by Africans. Invited Lecture at the Multilateral Initiative on Malaria (MIM) Conference, Nairobi, Kenya, 2-6 November 2009.
  • Discovering Drugs in Africa by Africans: Challenges and Opportunities. Invited Lecture in the Symposium “Global Roundup of Pharmaceutical Research Capabilities and Opportunities” at the 2nd International Conference on Drug Discovery and Therapy, Dubai, UAE, 1-4 February 2010. Representative for Africa (Representatives from each of six continents/regions were invited).
  • Integrating African Natural Products into Modern Paradigms of Drug Discovery: From Challenges to Opportunities. Invited Lecture at the International Conference on Pure and Applied Chemistry, Mauritius, 26-30 July 2010.
  • Mining African Biodiversity to Provide Advances in Drug Discovery & Development via Low Cost Medicinal Chemistry. Invited Lecture at the Swiss Tropical & Public Health Institute Symposium Human African Trypanosomiasis (sleeping sickness) – Towards new chemotherapeutic tools, Basel, Switzerland, 9-10 December 2010.
  • Setting up Technology Platforms in Africa to Facilitate An Integrated Approach to Antimalarial Drug Discovery. Invited Lecture at the European Union AntiMal-Royal Society of Chemistry (UK) conference Antimalarial Drugs: Chemistry, Development & Future Challenges. Royal College of Physicians, Regents Park, London, UK, 15-16 March 2011.
  • Invited Speaker and Panelist in session: “How Do You Solve a Problem Like Malaria?: Using Smart Science to Defeat an Age-Old Disease”, 7th World Conference of Science Journalists (WCSJ2011), Doha, Qatar, 27-29 June 2011.
  • Technology Platforms to Facilitate Drug Discovery from African Biodiversity and Safety Evaluation of African Traditional Medicines. Plenary lecture at the 14th Natural Products Research for East & Central Africa (NAPRECA) Symposium on Natural Products from African Biodiversity, 8-12 August 2011, ICIPE, Kenya.
  • Integration of ADME in Medicinal Chemistry Progression of Antiplasmodial Hits. Invited lecture at the 1st international conference on “Global Challenges for New Drug Discovery Against Tropical Parasitic Diseases”, Cancun, Mexico, 11-15 December 2011.
  • Biotransformation in Antimalarial Drug Discovery. Invited lecture at the Molecular Approaches to Malaria (MAM) Conference, Lorne, Victoria, Australia, 19-23 February 2012
  • Hit to Lead and Lead Optimization of Antimalarial and Antituberculosis Whole Cell Hits from a SoftFocus Library. Invited Lecture at the American Chemical Society (ACS) symposium entitled “Challenges in Phenotypic Whole Cell High throughput Screening and Medicinal Chemistry Optimization of Hits; Strategies to Discover Novel Antiparasitic and Antimycobacterial Agents”, 243rd ACS National Meeting 25-29 March 2012, San Diego, California, USA.
  • Integrated Synthetic Medicinal Chemistry & Biotransformation in Antimalarial Drug Discovery. Invited Keynote Lecture at the 12th Frank Warren Conference, 15-18 April 2012, Bloemfontein, South Africa.
  • Discovering Drugs Against Infectious Diseases in Africa: Challenges, Status & Opportunities. Invited Keynote Lecture at the Africa Health Congress 2012, 2nd Pan-African Infectious Diseases Conference, 10-11 May 2012, Johannesburg, South Africa.
  • Discovery, optimization and candidate selection of an aminopyridine antimalarial molecule with potential to be a component of a single-dose cure. Invited Lecture at the 2012 Grand Challenges Meeting in session Lead Optimization and Candidate Selection: Case Studies“, 10-13 December 2012, Ottawa, Canada.
  • Medicinal chemistry progression of phenotypic HTS hits for TB from SoftFocus libraries. Invited lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 21-26 July 2013, Lucca, Barga, Italy. Under session “Compounds”. 
  • Africa’s growing potential for drug discovery & development. Invited keynote speaker for the BIO AFRICA event on , 23-24 April 2014, Mauritius
  •  An Antimalarial 2-Aminopyridine Clinical Candidate: Discovery and Target Identification Studies. Invited lecture at the GlaxoSmithKline (GSK)/Society of Chemical Industries (SCI) conference “Towards New Therapeutics for Diseases of the Developing World”, 11-13 May 2014, GSK Tres Cantos , Madrid, Spain.

 

Comments on this entry are closed.